1. Home
  2. SNCR vs ONCY Comparison

SNCR vs ONCY Comparison

Compare SNCR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • ONCY
  • Stock Information
  • Founded
  • SNCR 2000
  • ONCY 1998
  • Country
  • SNCR United States
  • ONCY Canada
  • Employees
  • SNCR N/A
  • ONCY N/A
  • Industry
  • SNCR EDP Services
  • ONCY Pharmaceuticals and Biotechnology
  • Sector
  • SNCR Technology
  • ONCY Health Care
  • Exchange
  • SNCR Nasdaq
  • ONCY Nasdaq
  • Market Cap
  • SNCR 73.5M
  • ONCY 49.1M
  • IPO Year
  • SNCR 2006
  • ONCY 1999
  • Fundamental
  • Price
  • SNCR $7.36
  • ONCY $0.91
  • Analyst Decision
  • SNCR Strong Buy
  • ONCY Strong Buy
  • Analyst Count
  • SNCR 1
  • ONCY 4
  • Target Price
  • SNCR $13.00
  • ONCY $4.33
  • AVG Volume (30 Days)
  • SNCR 138.8K
  • ONCY 1.4M
  • Earning Date
  • SNCR 08-05-2025
  • ONCY 07-31-2025
  • Dividend Yield
  • SNCR N/A
  • ONCY N/A
  • EPS Growth
  • SNCR N/A
  • ONCY N/A
  • EPS
  • SNCR N/A
  • ONCY N/A
  • Revenue
  • SNCR $172,842,000.00
  • ONCY N/A
  • Revenue This Year
  • SNCR $2.07
  • ONCY N/A
  • Revenue Next Year
  • SNCR $5.42
  • ONCY N/A
  • P/E Ratio
  • SNCR N/A
  • ONCY N/A
  • Revenue Growth
  • SNCR 4.64
  • ONCY N/A
  • 52 Week Low
  • SNCR $6.00
  • ONCY $0.33
  • 52 Week High
  • SNCR $15.46
  • ONCY $1.53
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 55.92
  • ONCY 78.49
  • Support Level
  • SNCR $6.00
  • ONCY $0.71
  • Resistance Level
  • SNCR $7.67
  • ONCY $0.81
  • Average True Range (ATR)
  • SNCR 0.42
  • ONCY 0.09
  • MACD
  • SNCR 0.20
  • ONCY 0.02
  • Stochastic Oscillator
  • SNCR 81.44
  • ONCY 90.48

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: